RenovoRx, Inc. (RNXT)

NASDAQ: RNXT · USD

$1.42

+0.03 (+2.2%)· Recorded snapshot

Market cap	64.1M
Revenue (ttm)	2M
Net income (ttm)	-12.3M
EPS (ttm)	-$0.31
Shares out	45.1M
Volume	164,122
Beta	0.97

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2M
Net income (ttm): -12.3M
EPS (ttm): -$0.31
Market cap: 64.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-125.2

P25 n/aP50 n/aP75 n/a

ROIC-80.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All RNXT indicators

Market & fundamental data

Available fields

200

Groups with data

Currency

USD

Showing 200 of 200 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001574094
Company name	RenovoRx, Inc.
Country	United States
Country code	US
CUSIP number	75989R107
Earnings date	2026-11-05
Earnings time	amc
Employees	17
Employees change	7
Employees growth	70%
Enterprise value	$55M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2012
Industry	Biotechnology
IPO date	2021-08-26
Is primary listing	Yes
Is SPAC	No
ISIN number	US75989R1077
Last 10-K release date	2026-03-30
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$64.1M
Market cap category	Micro-Cap
Next earnings date	2026-11-05
Options	No
Price	$1.42
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	RNXT
U.S. state	California
Website	https://renovorx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-21.8%
EV/Sales	27.15x
FCF / EV yield	-22.25%
FCF yield	-19.03%
Forward EV/Sales	8.42x
Forward P/S	9.85x
P/B ratio	6.99x
P/S ratio	31.75x
Price / tangible book value	6.99x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	84.41%
Operating margin	-659.92%
Pretax margin	-621.71%
Profit per employee	$-722,647
Revenue per employee	$116,235
ROA	-64.9%
ROA (5Y)	-98.12%
ROCE	-136%
ROE	-125.23%
ROE (5Y)	-450.69%
ROIC	-80.41%
SBC / revenue	76.97%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	6
Gross profit growth	300.96%
Gross profit growth (Q)	183.7%
Net income growth years	0
Revenue growth	198.49%
Revenue growth (Q)	115.4%
Revenue growth (QoQ)	61.46%
Revenue growth quarters	3
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-71,000
Depreciation and amortization	$6,000
EBIT	$-13M
EBITDA	$-13M
EPS	$-0.31
FCF per share	$-0.26
Financing cash flow	$9.1M
Free cash flow	$-11.9M
Free cash flow minus SBC	$-13.5M
Gross profit	$1.7M
Investing cash flow	$-71,000
Net cash flow	$-2.8M
Net income	$-12.3M
Operating cash flow minus SBC	$-13.4M
Operating income	$-13M
Revenue	$2M
Stock-based compensation	$1.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-1.43
Book value per share	$0.20
Debt / equity	0.04
Long-term assets	$662,000
Long-term liabilities	$609,000
Net cash (debt)	$9.1M
Net cash / market cap	14.49%
Net cash growth	-24.6%
Net debt / equity	-1.01
Piotroski F-Score	3
Property, plant and equipment	$462,000
Shareholders' equity	$9M
Tangible book value	$9M
Tangible book value per share	$0.20
Total assets	$11.5M
Total cash	$9.5M
Total debt	$390,000
Total liabilities	$2.5M
WACC	9.54%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.16
Current assets	$10.8M
Current liabilities	$1.9M
Current ratio	5.74
Net working capital	$-422,000
Quick ratio	5.29
Working capital	$8.9M
Working capital turnover	0.19

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-34.4%
Dividend yield	0%
Shareholder yield	-34.4%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$1.15
1D price change	2.16%
1M price change	-16.87%
1M total return	-16.87%
1W price change	15%
1W total return	15%
1Y price change	20%
1Y return CAGR	20.02%
1Y total return	20%
20-day SMA	$1.30
200-day SMA	$1.10
3M price change	42.99%
3M total return	42.99%
3Y price change	33.98%
3Y return CAGR	10.24%
3Y total return	33.98%
50-day SMA	$1.56
50-day SMA vs 200-day SMA	50over200
52-week high	$2.59
52-week high date	2026-09-02
52-week low	$0.70
52-week low date	2025-11-14
5Y price change	-73.76%
5Y return CAGR	-23.48%
5Y total return	-73.76%
6M price change	58.6%
6M total return	58.6%
All-time high	$16.74
All-time high date	2021-08-30
All-time low	$0.53
All-time low date	2023-12-06
Average true range (ATR)	$0.11
Average volume	411.8K
Beta (1Y)	1.18
Beta (2Y)	0.86
Beta (5Y)	0.97
Change from 52-week high	-45.17%
Change from 52-week low	102.68%
Change from all-time high	-91.76%
Change from all-time low	160.08%
Change from open	2.16%
Day's gap	0%
Dollar volume	$233,053
High price	$1.42
Low price	$1.37
Monthly RSI	49.08
Open price	$1.39
Position in 52-week range	100%
Premarket change	3.6%
Premarket close	$1.39
Premarket price	$1.44
Premarket volume	658
Previous close	$1.39
Price vs 150-day SMA	20.21%
Price vs 20-day SMA	5.91%
Price vs 200-day SMA	25.57%
Price vs 50-day SMA	-11.25%
Relative volume	0.4
Return from IPO open	-83.15%
Return from IPO price	-84.56%
RSI	50.96
Sharpe ratio	0.59
Sharpe ratio (3Y)	0.51
Sharpe ratio (5Y)	0.15
Sortino ratio	0.99
Sortino ratio (3Y)	0.9
Sortino ratio (5Y)	0.31
Volume	164.1K
Weekly RSI	52.48
YTD price change	64.27%
YTD total return	64.27%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	39.2M
Float percentage	86.79%
Shares change (QoQ)	24.36%
Shares change (YoY)	34.4%
Shares held by insiders	3.45%
Shares held by institutions	10.9%
Shares outstanding	45.1M
Short % of float	2.21%
Short % of shares	1.92%
Short ratio	0.7 days

Deeper analysis on RNXT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this RNXT report

Is a complete RNXT research report available?

No complete published report is available for RenovoRx, Inc. (RNXT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

RenovoRx, Inc. (RNXT)

Price

Financial snapshot

Fair-value bridge

Latest news · RNXT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All RNXT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on RNXT

Frequently asked questions